Abstract
Background
Sequential increment of balloon diameter for endoscopic pneumatic dilatation is a protocol that is used for symptomatic relief in achalasia cardia. However, most of the studies evaluating its effectiveness are retrospective in nature. This study intended to look into the efficacy of the above protocol in a prospective fashion.
Methods
Consecutive patients of achalasia cardia (n = 72) attending gastroenterology department were subjected to graded dilatation with 30, 35, and 40 mm pneumatic balloon and followed up (median 48 weeks; range: 4–96 weeks) with Eckardt score. Efficacy was assessed by proportion of patients achieving and maintaining clinical remission (Eckardt score ≤ 3) without requiring surgery during follow-up.
Result
Overall 91% of patients (60 out of 66 with follow-up data) remained symptom free without requirement of surgery. Proportion of type 3 achalasia patients was significantly higher in the group requiring surgery compared to those who did not (p = 0.005). Threshold of 12 mm Hg in 4-week post-dilatation integrated relaxation pressure noted to predict future requirement of surgery in type 3 achalasia patients with sensitivity and specificity of 75% and 85%, respectively. Major adverse events requiring in-patient management were 2.9% with perforation noted in 1.9%.
Conclusion
A sequential increment of balloon diameter for pneumatic dilatation in achalasia is an effective mode of therapy to achieve and maintain clinical remission in achalasia. The incidents of adverse events are low in this approach. Type 3 achalasia patients are more likely to require surgery despite sequential dilatation.
Similar content being viewed by others
References
Francis DL, Katzka DA. Achalasia: update on the disease and its treatment. Gastroenterology. 2010;139(2):369–74.
Kadakia SC, Wong RK. Graded pneumatic dilatation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am J Gastroenterol. 1993;88:34–8.
Vela MF, Richter JE, Khandwala F, et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006;4(5):580–7.
van Hoeij FB, Prins LI, Smout AJPM, et al. Efficacy and safety of pneumatic dilation in achalasia: a systematic review and meta-analysis. Neurogastroenterol Motil. 2019;31(7): e13548.
Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol. 2013;108(8):1238–49.
Katsinelos P, Kountouras J, Paroutoglou G, et al. Long-term results of pneumatic dilation for achalasia: a 15 years’ experience. World J Gastroenterol. 2005;11:5701–5.
Chan KC, Wong SK, Lee DW, et al. Short-term and long-term results of endoscopic balloon dilation for achalasia: 12 years’ experience. Endoscopy. 2004;36:690–4.
Boztas G, Mungan Z, Ozdil S, et al. Pneumatic balloon dilatation in primary achalasia: the long-term follow-up results. Hepatogastroenterology. 2005;52:475–80.
Lynch KL, Pandolfino JE, Howden CW, et al. Major complications of pneumatic dilatation and Heller myotomy for achalasia: single-centre experience and systematic review of the literature. Am J Gastroenterol. 2012;107(12):1817–25.
Boeckxstaens GE, Annese V, des Varannes SB, European achalasia Trial Investigators, et al. Pneumatic dilatation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011;364(19):1807–16.
Moonen A, Annese V, Belmans A, et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2016;65(5):732–9.
Meng F, Li P, Wang Y, et al. Peroral endoscopic myotomy compared with pneumatic dilation for newly diagnosed achalasia. Surg Endosc. 2017;31(11):4665–72.
Ponds FA, Fockens P, Lei A, et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA. 2019;322(2):134–44.
Kahrilas PJ, Bredenoord AJ, Fox M, International High Resolution Manometry Working Group, et al. The Chicago Classifcation of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–74.
Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103:1732–8.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.
Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–5.
Pratap N, Kalapala R, Darisetty S, et al. Achalasia cardia subtyping by high-resolution manometry predicts the therapeutic outcome of pneumatic balloon dilatation. J Neurogastroenterol Motil. 2011;17(1):48–53.
Jain M, Baijal N, Srinivas M, et al. Retrospective study on symptoms and treatment modalities used and short-term follow up of achalasia cardia in Indian setting. JGH Open. 2020;4(5):856–9.
Ghoshal UC, Kumar S, Saraswat VA, et al. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol. 2004;99(12):2304–10.
Richter JE, Boeckxstaens GE. Management of achalasia: surgery or pneumatic dilation. Gut. 2011;60(6):869–76.
Vaezi MF, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomized trial. Gut. 1999;44(2):231–9.
Dobrucali A, Erzin Y, Tuncer M, et al. Long-term results of graded pneumatic dilatation under endoscopic guidance in patients with primary esophageal achalasia. World J Gastroenterol. 2004;10(22):3322–7.
Smeets F, Masclee A, Keszthelyi D, et al. Esophagogastric junction distensibility in the management of achalasia patients: relation to treatment outcome. Neurogastroenterol Motil. 2015;27(10):1495–503.
Mikaeli J, Bishehsari F, Montazeri G, et al. Pneumatic balloon dilatation in achalasia: a prospective comparison of safety and efficacy with different balloon diameters. Aliment Pharmacol Ther. 2004;20(4):431–6.
Aljebreen AM, Samarkandi S, Al-Harbi T, et al. Efficacy of pneumatic dilatation in Saudi achalasia patients. Saudi J Gastroenterol. 2014;20(1):43–7.
Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013;144(4):718–25 (quiz e13-14).
Ihara E, Muta K, Fukaura K, et al. Diagnosis and treatment strategy of achalasia subtypes and Esophagogastric junction outflow obstruction based on high-resolution Manometry. Digestion. 2017;95:29–35.
Ponce J, Garrigues V, Pertejo V, et al. Individual prediction of response to pneumatic dilation in patients with achalasia. Dig Dis Sci. 1996;41:2135–41.
Ghoshal UC, Rangan M, Misra A. Pneumatic dilation for achalasia cardia: reduction in lower esophageal sphincter pressure in assessing response and factors associated with recurrence during long-term follow up. Dig Endosc. 2012;24(1):7–15.
Funding
No funding was received for this study.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by AB, DM, and KD. The first draft of the manuscript was written by DM and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical statement
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent for it was obtained from all patients for being included in the study.
Conflict of interest
All the authors do not have any conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Misra, D., Banerjee, A., Das, K. et al. Outcome of sequential dilatation in achalasia cardia patients: a prospective cohort study. Esophagus 19, 508–515 (2022). https://doi.org/10.1007/s10388-021-00902-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-021-00902-5